Evidence map›Paper›PMID 37189079›Full record

ArticleBMC ophthalmology2023

Ophthalmic manifestations in children with Down Syndrome in Bogotá, Colombia.

William Rojas-Carabali, María Camila Cortés-Albornoz, Gabriela Flórez-Esparza, Carlos Cifuentes-González, Alejandra de-la-Torre, Claudia Talero-Gutiérrez

Open access · goldAbstract read
In one paragraph

Article in BMC ophthalmology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
0.9field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it, 4 citations in OpenAlex.

  1. Pooled it
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

William Rojas-CarabaliNeuroscience (NEUROS) Research Group, School of Medicine and Health Sciences, NeuroVitae Center for Neuroscience, Institute of Translational Medicine (IMT), Universidad del Rosario, Carrera 24 # 63C 69, Bogotá, Colombia.
María Camila Cortés-AlbornozNeuroscience (NEUROS) Research Group, School of Medicine and Health Sciences, NeuroVitae Center for Neuroscience, Institute of Translational Medicine (IMT), Universidad del Rosario, Carrera 24 # 63C 69, Bogotá, Colombia.
Gabriela Flórez-EsparzaNeuroscience (NEUROS) Research Group, School of Medicine and Health Sciences, NeuroVitae Center for Neuroscience, Institute of Translational Medicine (IMT), Universidad del Rosario, Carrera 24 # 63C 69, Bogotá, Colombia.
Carlos Cifuentes-GonzálezNeuroscience (NEUROS) Research Group, School of Medicine and Health Sciences, NeuroVitae Center for Neuroscience, Institute of Translational Medicine (IMT), Universidad del Rosario, Carrera 24 # 63C 69, Bogotá, Colombia.
Alejandra de-la-Torre *Neuroscience (NEUROS) Research Group, School of Medicine and Health Sciences, NeuroVitae Center for Neuroscience, Institute of Translational Medicine (IMT), Universidad del Rosario, Carrera 24 # 63C 69, Bogotá, Colombia. alejadelatorre@yahoo.com.ORCID http://orcid.org/0000-0003-0684-1989
Claudia Talero-Gutiérrez *Neuroscience (NEUROS) Research Group, School of Medicine and Health Sciences, NeuroVitae Center for Neuroscience, Institute of Translational Medicine (IMT), Universidad del Rosario, Carrera 24 # 63C 69, Bogotá, Colombia. claudia.talero@urosario.edu.co.ORCID http://orcid.org/0000-0003-1601-5015
Universidad del Rosario · CO

Funding

Ministerio de Ciencia, Tecnología e Innovación (CO) 887-2021
6 · The paper itself

Abstract

backgroundTo describe the ocular features of a cohort of children with Down Syndrome (DS) in Bogotá, Colombia.

methodsWe performed a cross-sectional study, evaluating 67 children with DS. A pediatric ophthalmologist performed a complete optometric and ophthalmological evaluation of each child, including visual acuity, ocular alignment, external eye examination, biomicroscopy, auto-refractometry, retinoscope in cycloplegia, and fundus examination. Results were reported as frequency distribution tables with percentages for categorical variables and means and standard deviation or median and interquartile ranges for continuous variables, according to their distribution. We used the Chi-square test or Fisher's exact test for categorical variables and ANOVA or Kruskal-Wallis for continuous variables when indicated.

resultsA total of 134 eyes from 67 children were evaluated. Males represented 50.7%. The children's age ranged from 8-16 years, with a mean of 12.3 (SD 2.30). The most frequent refractive diagnosis per eye was hyperopia (47%), followed by myopia (32.1%) and mixed astigmatism (18.7%). The most frequent ocular manifestations were oblique fissure (89.6%), followed by amblyopia (54.5%) and lens opacity (39.4%). Female sex was associated with strabismus (P = 0.009) and amblyopia (P = 0.048).

conclusionOur cohort had a high prevalence of disregarded ophthalmological manifestations. Some of these manifestations, such as amblyopia, can be irreversible and severely affect the neurodevelopment of DS children. Therefore, ophthalmologists and optometrists should be aware of the visual and ocular affection of children with DS to assess and provide appropriate management. This awareness could improve rehabilitation outcomes for these children.

Indexed as

AmblyopiaDown SyndromeRefractive ErrorsStrabismusAdolescentChildColombiaCross-Sectional StudiesFemaleHumansMalePrevalenceCross-sectionalDown SyndromeEyeOcular manifestationOphthalmology

Identifiers

PMID37189079
PMCPMC10184377
OpenAlexW4376642844

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.